|Bid||37.04 x 2200|
|Ask||37.11 x 900|
|Day's Range||36.85 - 37.21|
|52 Week Range||31.43 - 48.25|
|Beta (5Y Monthly)||0.31|
|PE Ratio (TTM)||37.37|
|Earnings Date||Feb 01, 2017 - Feb 06, 2017|
|Forward Dividend & Yield||2.03 (5.47%)|
|Ex-Dividend Date||Nov 12, 2020|
|1y Target Est||48.17|
AstraZeneca (AZN) COVID-19 vaccine candidate proves effective in late-stage study. Pfizer (PFE) seeks Emergency use for its COVID-19 vaccine candidate.
The Zacks Analyst Blog Highlights: UnitedHealth, CRM, GSK, Square and American Electric Power
With three vaccine candidates out with a first look at efficacy data, Wall Street is more optimistic about the light at the end of the pandemic tunnel.